The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology in China from Its Beginning to Today

Rheumatology in China from Its Beginning to Today

October 18, 2018 • By Xiaofeng Zeng, MD, & Qingping Yao, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Harvepino / shutterstock.com

Harvepino / shutterstock.com

Rheumatology in China is a relatively young discipline, but it has developed exponentially over the past three decades. In this article, we review the history of rheumatology in China and advances in clinical care, research and education in this field.

You Might Also Like
  • Speak Out Rheum: Attacks Against Healthcare Providers in China Spur Chinese Rheumatologists to Heal Strained Doctor–Patient Relationships Through Technology
  • China to Expand Medical Insurance for Major Illnesses
  • Bigger May Not Be Better for China’s ‘Super Hospitals’
Explore This Issue
October 2018

The Founding Father

Naizheng Zhang, MD, is widely regarded as the father of rheumatology in China. Rheumatology virtually did not exist in China before 1960, and its development really started at Peking Union Medical College Hospital (PUMCH), founded by the U.S.-based Rockefeller Foundation in 1921, one of the most prestigious medical institutions in China.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Zhang, who served in the Department of Medicine at PUMCH, was chosen by the Chinese government to study at the Institute of Rheumatology, Medical Sciences in the former Soviet Union in 1959. Dr. Zhang returned to China in 1960 and initiated a Clinic for Rheumatology Service at PUMCH. The Cultural Revolution and subsequent economic difficulties, unfortunately, delayed the further development of rheumatology for over a decade.

Under the leadership of Dr. Zhang in 1979, rheumatology clinical and investigational units were established in a few major hospitals in Beijing and Shanghai. Several internists with a special interest in rheumatology became the pioneers of rheumatology in China, including Dr. Zhang, Yi Dong, MD, and Ming Jiang, MD, of PUMCH; Xinhua Cai, MD, and Guiying Shi, MD, of the Chinese General Army Hospital; and Minxin Huang, MD, and Shunle Cheng, MD, of the Shanghai Second Medical University. Training rheumatology fellows in China began the same year, and the first group of trainees included Fulin Tang, MD, Qingyu Zeng, MD, Mengxue Yu, MD, and Donghai Wu, MD, all of whom trained under the mentorship of Dr. Zhang.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In 1982, as the rheumatology workforce increased in size, a rheumatology consortium was formed. Three years later, the Chinese Rheumatology Association (CRA) was officially founded, with Dr. Zhang as its inaugural president.1

Serologic Testing & Epidemiologic Study

First row from left: Ms. Qinfang Song, Ms. Li Shi, Ms. Yanping Shi, Xiaodan Gan, MD. Second row from left: Xuejun Zeng, MD, Chunli Yan, Ming Jiang, MD, Yi Dong, MD, Mengxue Yu, MD. Third row from left: Xiaofeng Zeng, MD, Qingping Yao, MD, PhD, Naizheng Zhang, MD, Fulin Tang, MD. Not pictured: Dr. Fengchun Zhang.

First row from left: Ms. Qinfang Song, Ms. Li Shi, Ms. Yanping Shi, Xiaodan Gan, MD. Second row from left: Xuejun Zeng, MD, Chunli Yan, Ming Jiang, MD, Yi Dong, MD, Mengxue Yu, MD. Third row from left: Xiaofeng Zeng, MD, Qingping Yao, MD, PhD, Naizheng Zhang, MD, Fulin Tang, MD. Not pictured: Dr. Fengchun Zhang.

In the early 1980s, rheumatoid factor was the only serologic test for any rheumatic illness available in China. Fulin Tang, MD, an attending rheumatologist at PUMCH, was sent by Dr. Zhang to study at the University of Southern California in Los Angeles. He brought back experimental methodologies for measuring anti-nuclear antibodies. These early serologic tests were gradually introduced to other hospital laboratories across the country.

Pages: 1 2 3 4 | Single Page

Filed Under: Professional Topics, Profiles Tagged With: China, Dr. Naizheng Zhang, HistoryIssue: October 2018

You Might Also Like:
  • Speak Out Rheum: Attacks Against Healthcare Providers in China Spur Chinese Rheumatologists to Heal Strained Doctor–Patient Relationships Through Technology
  • China to Expand Medical Insurance for Major Illnesses
  • Bigger May Not Be Better for China’s ‘Super Hospitals’
  • China Gets Tougher for Western Drugmakers

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.